Tucker Sean 4
4 · Vaxart, Inc. · Filed Apr 25, 2022
Insider Transaction Report
Form 4
Vaxart, Inc.VXRT
Tucker Sean
SVP, Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2022-04-22−40,000→ 84,061 totalExercise: $0.77Exp: 2029-05-11→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2022-04-22$0.77/sh+40,000$30,800→ 127,631 total
Holdings
- 51,465(indirect: By joint tenancy with Frances Chang and Sean Tucker)
Common Stock
- 9,060(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares in 36 equal monthly installments thereafter.